Subsequently, we evaluated the adoptive transfer CD39+ Tregs for use in the immunotherapy of ALI mice and explored the potential mechanism affecting CD39 expression on Tregs. The gene discussed is ENTPD1; the disease is acute respiratory distress syndrome.